90 - Less Sugar, More Blood
The Curious Clinicians
Exploring the Impact of SGLT2 Inhibitors on Hemoglobin and Hematocrit Levels
The chapter delves into the effects of SGLT2 inhibitors on hemoglobin and hematocrit levels, discussing research findings and potential mechanisms behind these changes. The speakers analyze percentages of increase in hemoglobin and hematocrit from various trials, reflecting on the implications for medical practice.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
